Clinical Trial News and Research

RSS

FDA expands approval of novel diabetes management device to include younger pediatric patients

The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes.

21 Jun 2018

Probiotics could cut age-related bone loss in elderly women

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteria, can be used to affect the human skeleton.

21 Jun 2018

UT Southwestern scientists identify gene mutation linked with perplexing brain condition

Scientists conducting one of the largest full DNA analyses of a rare disease have identified a gene mutation associated with a perplexing brain condition that blinds and paralyzes patients.

20 Jun 2018

Researchers employ nucleotide-based gene silencing to mitigate common ataxia

In what researchers are calling a game changer for future ataxia treatments, a new study showed the ability to turn down the disease progression of the most common dominantly inherited ataxia.

20 Jun 2018

LabConnect collaborates with Symphony to support clinical research industry

LabConnect, LLC, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, and Symphony Clinical Research, a worldwide, innovative in-home clinical service provider, today announced a strategic collaboration.

20 Jun 2018

KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay

KIYATEC, Inc. today announced the enrollment of the first patients in a U.S. clinical study of its Ex Vivo 3D drug response assay across several difficult-to-treat solid tumors.

20 Jun 2018

Dual-therapy approach can help boost motor recovery in stroke victims

Paralysis of an arm and/or leg is one of the most common effects of a stroke. But thanks to research carried out by scientists at the Defitech Foundation Chair in Brain-Machine Interface, in association with other members of EPFL's Center for Neuroprothetics, the Clinique Romande de Réadaptation in Sion, and the Geneva University Hospitals, stroke victims may soon be able to recover greater use of their paralyzed limbs.

20 Jun 2018

New approach could provide objective and easy-to-obtain measure of dietary adherence

An analysis of small molecules called "metabolites" in a blood sample may be used to determine whether a person is following a prescribed diet, scientists at Johns Hopkins Bloomberg School of Public Health have shown.

20 Jun 2018

New study is testing safety and efficacy of glycoside in breaking up kidney stones

For anyone who has suffered from kidney stones, the painful condition is not easily treatable, and patients are typically prescribed strong pain medication and fluids to alleviate symptoms.

20 Jun 2018

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial.

19 Jun 2018

New guidance on selection and evaluation of wearable devices for use in regulatory clinical trials

Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new guidance regarding the selection and evaluation of wearable devices for use in regulatory trials and to support labeling claims.

19 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Research from the Department of Inflammation Biology, School of Immunology & Microbial Sciences has shown there is an increased risk of disease flare in Rheumatoid Arthritis patients who suffer from depression.

19 Jun 2018

Study hints at benefits of lifestyle interventions in reducing dementia risk

There is no treatment yet for dementia; but one day, a family doctor could prescribe a specific diet, an exercise regime, music or language lessons, or documentary discussion groups as treatments to ward off the disease.

19 Jun 2018

Scientists develop novel computational framework to support personalized cancer treatment

Researchers at Columbia University Irving Medical Center have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

19 Jun 2018

New clinical trial finds no evidence to support use of tamsulosin for kidney stones

The latest research into finding medications to aid the passage of ureteral or kidney stones has shown that tamsulosin is not effective for patients across the board.

18 Jun 2018

Scientists discover genetic causes underlying group of related infant cancers

The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators.

18 Jun 2018

New stimulation method increases hope for improving disorders of consciousness

To diagnose patients with severe brain injuries reliably, their state of consciousness has to be evaluated several times with suitable tools.

18 Jun 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Clinical Trial News and Research

FDA expands approval of novel diabetes management device to include younger pediatric patients

Probiotics could cut age-related bone loss in elderly women

UT Southwestern scientists identify gene mutation linked with perplexing brain condition

Researchers employ nucleotide-based gene silencing to mitigate common ataxia

LabConnect collaborates with Symphony to support clinical research industry

KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay

Dual-therapy approach can help boost motor recovery in stroke victims

New approach could provide objective and easy-to-obtain measure of dietary adherence

New study is testing safety and efficacy of glycoside in breaking up kidney stones

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

New guidance on selection and evaluation of wearable devices for use in regulatory clinical trials

Clinical trial targets metastatic colorectal cancer with new combination therapy

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Study hints at benefits of lifestyle interventions in reducing dementia risk

Scientists develop novel computational framework to support personalized cancer treatment

New clinical trial finds no evidence to support use of tamsulosin for kidney stones

Scientists discover genetic causes underlying group of related infant cancers

New stimulation method increases hope for improving disorders of consciousness

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer